Trademark: MODERNA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for MODERNA
We do not have any records of a proof of use for MODERNA at this moment.
Possible trademark infringements of MODERNA
Basic Information about MODERNA
- Serial Number
- 88929991
- Filing Date
- 22 May 2020
- Registration Number
- 7279641
- Registration Date
- 16 Jan 2024
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of MODERNA on the blockchain with WikiTrademarks.io.
- First use of MODERNA anywhere
- MODERNA was first used on 30 May 2013 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of MODERNA anywhere
- MODERNA was first used on 30 May 2013 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of MODERNA anywhere
- MODERNA was first used on 06 Dec 2012 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns MODERNA?
Correspondent
- John Francis Ward Moderna
- 325 Binney Street
- Cambridge, MA 02142
- United States
Recent News about MODERNA
Other Barks & Bites for Friday, October 18: OpenAI Outlines Defensive Patent Strategy; Microsoft Files Opposition in Lawsuit Alleging Illegal Buyer’s Cartel for Patent Licenses; Moderna Under Fire for Spikevax Vaccine Tech Tweet this
Northwestern University Sues Moderna Over Spikevax Vaccine Tweet this
Why one letter could help Moderna avoid TM rejection Tweet this
Other Barks & Bites for Friday, March 24: Non-DOCX Fee Delayed Further; SCOTUS Petition Says Hirshfeld’s Review of PTAB Decision Violated Federal Vacancies Reform Act; Moderna CEO Grilled by Senate Committee over COVID Vaccine Price Hike Tweet this
Other Barks & Bites for Friday, December 9: United States Supports Delaying Decision on TRIPS IP Waiver Extension; Pfizer Countersues Moderna over Vaccines; Ericsson and Apple Settle Tweet this
Other Barks & Bites for Friday, November 4: CAFC Offers Mixed Bag in Uniloc Appeals, Global Music Copyright Market Valued at Nearly $40 Billion, and Moderna Loses Bid to Have U.S. Government Face Vaccine Patent Claims Tweet this
Moderna sues Pfizer, BioNTech over COVID-19 mRNA Vaccine Patents Tweet this
Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space Tweet this
This week in IP: Nokia hits 4,000 5G SEP families, Moderna and NIH debate patent creds, and more Tweet this
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io